1. Please check and comment entries here.
Table of Contents

    Topic review

    Terpenoid Lactones

    View times: 10
    Submitted by: Alicja Surowiak

    Definition

    Terpenoids with lactone moieties have been indicated to possess various biological activities. Certain terpenoid lactones exist in nature, in plants and animals, but they can also be obtained by chemical synthesis. Terpenoids possessing lactone moieties are known for their cytotoxic, anti-inflammatory, antimicrobial, anticancer, and antimalarial activities. 

    1. Antimicrobial Activity

    Various terpenoid lactones of both natural and synthetic origin possess antimicrobial activities. Pickman et al. reported that the sesquiterpenoid lactones from sunflowers, alantolactone and isoalantolactone (Figure 1), are active against the fungi Sclerotinium sclerotiorum and Verticillium dahliae, which are responsible for verticillium wilt, and the results were satisfactory [1]. In another study, it was indicated that both sunflower lactones have great antifungal activity against isolates of Leptosphaeria maculans, Verticillium albo-atrum, and Fusarium graminearum with low MIC (minimal inhibitory concentration) values ranging from 1 to 5 ppm [2]. This might be related to lipophilic character of its structures that facilitate their penetration through the cell wall [3].

    Figure 1. Lactones from sunflowers (a,b).

    The Villarreal group reported that lactones from Asteraceae species have both antibacterial and anti-yeast actions. They tested various lactones from the germacrolide, heliangolide, and eremophilanolide groups against Escherichia coli (ATCC8937), Pseudomonas aeruginosa (ATCC9027), Staphylococcus aureus (ATCC6538), and Candida albicans (ATCC10231). The results proved that almost all tested lactones were good growth inhibitors with MIC values ranging from 50–400 µg/mL [4]. There are also active lactones among terpenoids from the soft coral genus Sinularia [5]. Flexibilide and sinulariolide (Figure 2) both possess an α-methylene-lactone moiety. Both showed activity against Bacillus subtilis and S. aureus, although they were not active against fungi and Gram-negative bacteria. The authors indicated that the activity of those compounds is related to the alkylating centers or hemiacetal moieties in the molecule [6].

    Figure 2. Lactones from soft coral possessing an α-methylene-lactone moiety (a,b).

    Neves and colleagues tested the sesquiterpenoid lactones dehydrocostus lactone, acetyltriflocusolide lactone, and 11-αH-dihydrodehydrocostus lactone from Portuguese liverwort (Figure 3). All presented activity against Cladosporium cucumerinum, with the best result obtained for dehydrocostus lactone. This lactone was also the only lactone that presented activity against C. albicans [7].

    Figure 3. Sesquiterpene lactones from Portuguese liverwort (ac).

    Kozioł et al. synthesized a 4-tert-butylcyclohexanone bromolactone derivative (Figure 4a), which was proven to inhibit the growth of E. coli, S. aureus, and B. subtilis. Additionally, at a concentration of 200 μg/mL, up to 60% of bacterial growth was inhibited [8]. Another previous study analyzed the antibacterial activity of bromolactone with a preserved carane system (Figure 4b). This bromolactone proved to have satisfactory growth inhibitory activity with an MIC90 value of 200 μg/mL [9].

    Figure 4. Bromolactone derivatives of monoterpenoids (a,b).

    Mazur and colleagues synthesized anisaldehyde lactone derivatives and evaluated their antibacterial activity. One of the tested compounds (Figure 5) presented significant activity against two strains tested: S. aureus and Listeria monocytogenes. The MIC80 values were 50 and 100 µg/mL, respectively [10].

    Figure 5. An anisaldehyde lactone derivative.

    A series of lactones were prepared from natural aromatic aldehydes by the Skrobiszewski group. All γ-butyrolactones were tested for their antifungal activity against four Fusarium strains, and three γ-butyrolactones (Figure 6) presented strong activity. The first derivative (Figure 6a) presented considerably high activity (50%) against F. avenaceum and F. oxysporum. The second lactone (Figure 6b) was the most active; against F. oxysporum, it showed 70% growth inhibition, and against F. avenaceum, F. solani, and F. culmorum, this lactone displayed 66%, 66%, and 55% growth inhibition, respectively. The third compound (Figure 6c) also exhibited approximately 50% activity against F. avenaceum, F. solani, and F. culmorum. Moreover, it was proposed that the reason for such results was that the most active compounds possess a benzodioxol ring at the β-position [11].

    Figure 6. γ-Butyrolactones with a benzodioxol ring at the β-position (ac).

    Terpenoid constituents from Aglaia forbesii seeds were obtained by the Joycharat group. Isoeichlerialactone, which is a derivative of 3,4-secodammarane, and a second lactone, a derivative of dammaran-3-one (isocabralealactone), were tested against Phytophthora botryosa, Phytophthora palmivora, and Rigidoporus microporus. Isoeichlerialactone was active against all phytopathogens tested and showing the best activity against R. microporous with a MIC and MFC (minimum fungicidal concentration) value of 62.5 µg/mL. However, isocabralealactone was active only against R. microporous with MIC and MFC values of 125 and 250 µg/mL, respectively [12]. Fernaández et al. verified the antifungal activity of lactones derived from Hyalis argentea var. latisquama against Cryptococcus neoformans and C. albicans. Lactone derivatives of lindenanolides were the most active. The lowest concentrations that obtained 100% inhibition were 62.5 μg/mL and 125 μg/mL, respectively, for one of the lactone derivatives [13]. The antifungal activities of natural and synthetic sesquiterpenoid lactones were tested against phytopathogens by Wedge and colleagues. Two compounds (Figure 7) had significant and moderate activities. One of the compounds (Figure 7b) at a 30 μM concentration reduced Colletotrichum fragariae growth by 90%, Colletotrichum gloeosporioides by 89%, and Colletotrichum acutatum by 29% but was not active against Botrytis cinerea or F. oxysporum. The other compound (Figure 7a) was the only compound active against B. cinerea with 22% inhibition at a concentration of 30 μM. It might be concluded that those compounds play a plant defense role in maintaining leaf integrity by inhibiting foliar pathogens [14].

    Figure 7. Lactones from the guajanolide class (a,b).

    Forville de Andrade and colleagues verified the antibacterial activity of a sesquiterpenoid lactone mixture extracted from yacon. It is a mixture of two lactones: enhydrin and uvedalin. The only microorganism susceptible to this mixture was S. aureus (ATCC 29213), and the MIC value was 750 μg/mL. The authors state that its activity might be related to its lipophilicity and weak polarity [15]. Costunolide and eremanthin isolated from Costus speciosus were not active against bacteria, although they proved satisfactory antifungal activity against Trichophyton mentagrophytes, Trichophyton simii, Trichophyton rubrum 296, Trichophyton rubrum 57, Aspergillus niger, Epidermophyton floccosum, Curvularia lunata, Magnaporthe grisea, and the MIC value were ranging from 31.25 to 250 μg/mL [16]. There is a relation between lactone structure and its antimicrobial activity, but further studies on the mode of action should have been undertaken. In many cases, its lipophilicity and low polarity support the antimicrobial activity of terpenoid lactones. It might be considered that as most plant secondary metabolites their main target is the cytoplasmic membrane and they can affect its structure and integrity, permeability, or functionality [17].

    2. Cytotoxicity and Anticancer Activity

    The therapeutic use of cytotoxic compounds or the drugs containing them might cause side effects. Thus, it is important to verify their impact on healthy cells. In contrast, cytotoxicity to cancerous cells might be able to be used as a therapeutic agent. Many lactones are known for their cytotoxicity in both healthy and tumor cells. Lactones occurring in nature become scaffolds for further synthesis of active compounds [18]. The cytotoxicity of artemisinin, a lactone of natural origin, was proven by Zheng. In this study, artemisinin showed activity against P-388 (mouse lymphocytic leukemia), A-549 (human lung carcinoma), and HT-29 (human colon adenocarcinoma) tumor cells with ED50 (the concentration that caused a 50% inhibition of cell growth) values ranging from 9.62 × 10−2 μg/mL to 4.41 μg/mL [19]. Choi et al. presented results on the cytotoxicity of terpenoid lactones from roots of Ainsliaea acefifolia. Among all of the extracted compounds they identified, were mokko lactone, zaluzanin C, and glucozaluzanin C. They tested their compounds in vitro against the following tumor cells: A549, SK-OV-3 (ovarian), SK-MEL-2 (skin melanoma), XF498 (CNS), and HCT15 (colon). The best result was obtained from zaluzanin C (ED50 = 0.36 μg/mL) and then by glucozalazuanin (ED50 = 0.40 μg/mL) in both skin melanoma cells lines. The remaining results ranged from 1.05 μg/mL to 2.73 μg/mL [20]. The Duh group tested the cytotoxicity of terpenoids from Formosan Soft Coral against A549, HT-29, KB (human epidermoid carcinoma), and P-388 cell cultures. Both lactones tested (Figure 8) were cytotoxic, but the cytotoxicity of the lactone acetate was significant: 3.03 μg/mL, 0.81 μg/mL, 0.72 μg/mL, and 1.20 μg/mL against the cell lines, respectively [21].

    Figure 8. Terpenoid lactones from Formosan Soft Coral (a,b).

    Woerdenbag and colleagues analyzed the cytotoxicities of sesquiterpenoid lactones from Arnica montana flowers on the human carcinoma cells GLC-4 (lung small cell carcinoma) and COLO 320 (colon adenocarcinoma). Helenalin was far more cytotoxic than its esters. The lack of the ester group is probably responsible for its cytotoxicity, as there is an exocyclic methylene group fused to a lactone ring. Derivatives that did not have this group were 50–150 times less potent. Its cytotoxicity is correlated with the ability to undergo Michael-type reaction with biological nucleophiles [22]. Stojakowska et al. verified the cytotoxicity of the major terpenoids from Telekia speciosa. Asperilin (Figure 9) was moderately cytotoxic against PC3 (prostate carcinoma) cells in vitro (IC50 of 58.5 μM) and against melanoma cells (A375, WM793, and Hs294T) with IC50 values (the concentration that caused the death of 50% of cells) of 17.6 μM, 28.2 μΜ, and 29.5 μΜ, respectively. Authors recommend further studies on molecular mechanisms of action [23].

    Figure 9. Asperilin.

    Vernolides A and B, sesquiterpenoid lactones, were tested by the Kuo group against the KB, DLD1 (colon adenocarcinoma), NCI661 (lung large cell carcinoma), and HELA (cervical epithelioid carcinoma) tumor cell lines. Vernolide A was more cytotoxic (ED50 of 0.02, 0.05, 0.53, 0.04 μg/mL, respectively) than Vernolide B, which showed up to 180 times weaker cytotoxicity, further studies on structure-activity relation are recommended [24]. Maldonado and colleagues found a new terpenoid lactone from Kaunia lasiophthalma (Griseb.) and named it kaunial (Figure 10). Kaunial was significantly cytotoxic against the breast cancer lines L56BrC1 (IC50 = 0.98 μΜ) and SKBR-3 (IC50 = 1.6 μΜ), but also to healthy human cells. The presence of Michael acceptor is recognized as a factor that enhances its activity [25].

    Figure 10. Kaunial.

    Two C-11 terpene lactones (loliolide and isololiolide) were isolated from Heliotropium bacciferum Forssk. Their cytotoxicity was verified in the HCT116 (human colon cancer) and DLD1 cell lines. Both lactones showed IC50 values ranging from 0.306 to 0.351 mM in HCT116 cells and between 0.236 and 0.395 mM in DLD1 cells [26]. A wider group of lactones from the genus Sinularia proved to have cytotoxic activity rather than antimicrobial activity [5]. Both flexibilide and sinulariolide (Figure 2) are cytotoxic [27]. In vitro, sinulariolide was tested against the human KB, A-549, HT29, and P388 cell lines. The results were 7.6 μg/mL, 3.0 μg/mL, 3.1 μg/mL, and 3.9 μg/mL, respectively [28]. The same lactones as those from the antimicrobial test were evaluated by the Villarreal group against the KB, P388, and KBVI (vinblastine-resistant KB) cell lines. Lactones from the germacrolide and heliangolide groups were active against all of the cells, whereas eudesmane was moderately active against P388 cells [4]. Pawlak and colleagues synthesized two trans-β-aryl-δ-iodo-γ-lactone isomers from 2,5-dimethylbenzaldehyde and tested their cytotoxicity against CLB70 (chronic lymphoid leukemia), GL1 (acute canine lymphoid leukemia), and Jurkat (acute human lymphoid leukemia) cells. Both isomers showed 80% dead cells after treatment with 50 μg/mL solution, although the dextrorotatory isomer was more potent. Apoptosis was induced by a classic caspase-dependent pathway. Inhibition of two anti-apoptotic proteins (Bcl-xL and Bcl-2) was observed. Canonical apoptotic cell death was connected with phosphatidylserine exposure and caspase 3/7 activation. A decrease of the presence of anti-apoptotic proteins is followed by the activation of caspases and cleavage of PARP in the nucleus [29]. The antiproliferative activities of synthetic lactones towards similar cells, D17 (canine osteosarcoma cells) and CLBL1 (a canine B-cell lymphoma cell line) were tested by Gładkowski et al. Both stereoisomers of several compounds were evaluated, and the results showed that the trans-isomers were more active. The best results were obtained for (−)-trans-(4S,5R,6S)-5-(1-iodoethyl)-4-(benzo[d][1′,3′]-dioxol-5′-yl)dihydrofuran-2-one with IC50 values of 5.29 ± 0.31 μg/mL (Jurkat), 16.65 ± 2.56 μg/mL (D17), 5.08 ± 0.41 μg/mL (GL1) and 9.10 ± 0.96 μg/mL (CLBL1). Additionally, significant results were obtained for two other compounds, (−)-trans-(4S,5R,6S)-5-(1-iodoethyl)-4-(2′,5′-dimethylphenyl)dihydrofuran-2-one and its dextrorotatory form, with IC50 values ranging from 4.76 ± 0.52 μg/mL to 16.99 ± 4.88 μg/mL [30]. In his earlier study, other cytotoxic lactones emerged (Figure 11). Iodolactone (Figure 11a) displayed 83.7 ± 5.7% (Jurkat) and 35.2 ± 9.6% (D17) dead cells. Bromolactone (Figure 11b) resulted in 51.1 ± 8.9% (D17) and 47.6 ± 6.4% (Jurkat) dead cells [31].

    Figure 11. Iodo- (a) and bromolactone (b) from simple aromatic aldehydes.

    The Lage group evaluated the antitumor activity of lactones against multidrug-resistant cell cancer lines: EPG85-257P (parental, drug-sensitive gastric carcinoma), EPG85-257RDB (gastric carcinoma with the classical MDR phenotype), EPG85-257RNOV (gastric carcinoma with an atypical MDR phenotype), EPP85-181P (parental, drug-sensitive pancreatic carcinoma), EPP85-181RDB (pancreatic carcinoma with the classical MDR phenotype), EPP85-181RNOV (pancreatic carcinoma with an atypical MDR phenotype), HT29P (parental, drug-sensitive colon carcinoma), HT-29RDB (colon carcinoma with the classical MDR phenotype) and HT29RNOV (colon carcinoma with an atypical MDR phenotype). The diterpenic α,β-unsaturated lactones helioscopinolide B, its acetylated derivative, and helioscopinolide E were effective, showing IC50 values of 5.7, 4.6, and 4.4 μM against the EPG85-257RDB cell line. The mechanism of action is related to the individual drug-resistant phenotype. The anticancer effects are not associated with a single factor, as a multimodal-mediated biological mechanism [32]. The nagilactone E a terpenoid isolated from Podocarpus nagi possesses anticancer activity towards lung cancer cells (A549). The mode of action of this group of compounds is omnidirectional. It is known that nangilactone E is a protein synthesis inhibitor [33]. It was also observed that it increases expression of PD-L1 (Programmed death-ligand 1) through activation of c-Jun (the protein encoded by JUN gene, the component of activator protein-1 pathway) and further leads to exposure to the plasma membrane of cancer cells [34]. Nimbolide is another lactone with potential in the treatment of cancer. It inhibits cell proliferation of MDA-MB-231 and MCF-7 (breast cancer) by inducing apoptosis signaling especially through activation of caspases and reduction proteins Bcl-2 which resulted in inhibiting cell progression and survival [35]. Against other breast cancer cells (TNBC) it also proved its activity by inhibiting cell growth via induction of apoptosis and anti-metastatic effects [36]. The same compound proved also activity to HONE-a cells (nasopharyngeal carcinoma) by inhibiting cell viability t induction of cell apoptosis via modulating extracellular signal-regulated kinases 1 and 2 and activation of caspases [37].

    3. Anti-Inflammatory Activity

    Inflammation is a very complex phenomenon, and therapeutic agents might impact different aspects of this process. Inflammation is initiated by the secretion of proinflammatory cytokines such as interleukin 6 (IL-6), interleukin 8 (IL-8), and tumor necrosis factor (TNF-α), as well as the production of reactive oxygen species. Dai and colleagues revised the anti-inflammatory activity of andrographolide and its derivatives. They verified their ability to inhibit NO (nitric oxide) and PGE2 (prostaglandin E2) production, and also verified their impact on dimethylbenzene-induced mouse ear edema and egg albumin-induced rat paw edema. Three compounds (Figure 12) inhibited ear edema in mice at a dose of 0.90 mmol/kg body weight. Additionally, satisfactory results were observed against rat edema, with lactone c in Figure 12 showing the best reduction results at a dose of 0.90 mmol/kg body weight. All three compounds reduced PGE2 production at 1.35 mmol/kg and increased vascular permeability. At this same concentration, two compounds (Figure 12a,b) reduced NO production. Once again, compound c in Figure 12 obtained the best result at the dose of 0.90 mmol/kg. The great anti-inflammatory activity of compound c in Figure 12 is caused by the inhibition of iNOS activity and the reduction of NO production, moreover, it was the most potent α-glucosidase inhibitor [38].

    Figure 12. Andrographolide (a) and its derivatives (b,c).

    In another study, the ability of andrographolide to inhibit LPS-induced (lipopolysaccharide-induced) TNF-α and IL-6 expression was tested. Inhibition of 62.54% lipopolysaccharide-induced TNF-α and 56% inhibition of IL-6 were observed. Additionally, other derivatives of this compound were synthesized and evaluated for their anti-inflammatory potential, proving that compounds with the 12-hydroxyl-14-dehydroandrographolide structure have higher inhibitory potential than those with isoandrographolide structures. The underlying mechanisms were not presented [39]. The Chib group synthesized psilostachyin, which is an acetylated pseudoguaianolide, and its derivatives and analyzed their anti-inflammatory potential by in vitro expression of TNF-α, IL-1β, and IL-6 in murine neutrophils. Three analogs (Figure 13) displayed good inhibitory effects on TNF-α cytokine secretion (a = 49.21%, b = 59.76% and c = 53.12%). Slightly worse results were obtained for the expression of IL-1β (a = 36.04%, b = 41.37% and c = 40.86%), and no significant results were determined for IL-6 (a = 11.32%, b = 14.01% and c = 17.06%). Both of these last two sets of results are expressed as the % inhibition against LPS [40].

    Figure 13. Psilostachyin derivatives (ac).

    11α-13-Dihydrohelenalin ester derivatives from Arnica flowers were tested for their croton oil-induced mouse ear edema inhibitory activity. The percent inhibition ranged from 54% to 77% the underlying mechanisms were analyzed for Arnica flower tinctures and not for particular compounds. It was observed that stimulation of TNF-α induced DNA binding activity in Jurkat T cells–NF-κB p50/p65 heterodimer. Additionally, NF-κB DNA binding in an EMSA (electrophoretic mobility shift assay) and NF-AT (Nuclear factor of activated T-cells) DNA binding were weakened [41]. NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) inhibitors were synthesized by Schorr and colleagues. It was proven that uvedalin inhibited NF-κB DNA binding at the concentrations of 2.5 μM in Jurkat T cells and 5.0 μM in RAW 264.7 cells (Abelson murine leukemia virus-induced tumor cells); moreover, no cytotoxic effects were observed. At a concentration of 10 μM, the NF-κB DNA binding process was inhibited by enhydrin. Both compounds inhibited the factor NF-κB transcription [42]. The impact of highly oxidized sesquiterpenoids from Artemisia was tested by Chi et al. Six terpenoids possessing an α-methylene-γ-lactone moiety proved their anti-inflammatory potential in a model of LPS-induced NO production in RAW 264.7 cells with IC50 values of 2.38–10.67 μM [43]. This same model was applied by Xia and colleagues for the analysis of sesquiterpenoids from the essential oil of Curcuma wenyujin. Two lactones, isogermafurenolid and curdionolide B (Figure 14), exhibited satisfactory inhibitory effects with IC50 values of 30.62 and 14.50 μM, respectively [44].

    Figure 14. Sesquiterpenoid lactones from Curcuma wenyujin (a,b).

    A pseudopterane diterpene (Figure 15) was thoroughly examined for its anti-inflammatory potential. This compound not only decreased the production of the mediators TNF-α, IL-6, IL-1β, IP-10 (interferon γ-induced protein), iNOS (inducible oxide synthase), COX2 (cyclooxygenase 2), and MCP-1 (monocyte chemoattractant protein 1) induced by LPS in macrophages but also inhibited the degradation of IκBα (nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor alpha) and the activation of NFκB, reducing the expression of the costimulatory molecules CD80 and CD86 in the LPS-induced process. All regulations might concern the transcriptional level [45].

    Figure 15. Pseudopterane diterpene.

    Plaunolide is one of the components of the leaf crude extract of Croton stellatopilosus. Plaunolide was also proven to have significant inhibitory activity towards NO production in LPS-induced RAW 264.7 cells with an IC50 of 17.09 μM; moreover, it was nontoxic to cells. It can downregulate the expressions of the COX-1, COX-2, and iNOS genes [46]. Randainin D, a new diterpenoid found in Callicarpa randaiensis, exhibited mild inhibition of elastase release and moderate superoxide anion generation inhibitory activity of 35.9% at a concentration of 28.6 μM and an IC50 value of 21.5 μM [47]. New inositol lactones with anti-inflammatory potential isolated from Inula montana showed an impact on the release of NO on RAW 264.7 macrophages with IC50 values below 30 μM [48]. Shizukaol B is a lactone found in Chloranthus henryi, and this compound showed inhibition of inflammatory mediators such as iNOS and COX-2 after LPS stimulation. Anti-inflammatory effect is related to inhibition of expression of iNos and COX-2, blocking JNK (c-Jun N-terminal kinase) phosphorylation and c-Jun phosphorylation, attenuated c-Jun nuclear translocation. Moreover, shizukaol B inhibited the binding activity of AP-1 to DNA oligonucleotide [49]. From another plant from the Chloranthus genus, new chololactones were extracted. All of the compounds had a moderate activity with IC50 values of 4.4–35.4 μM [50]. Another study identified zaluzanin C as a potential inhibitory agent of NO production in RAW 264.7 macrophages with an IC50 value of 6.54 μM [51]. Nagilactones in a form of glucoside inhibit NF-κB activity what suppress LPS-induced NO production on RAW264.7 macrophages The phosphorylation of IKKα/β, IκBα, and p65 was reversed, by what the translocation of NF-κB/p65 from the cytoplasm to nucleus was prevented. Which resulted in the suppression of iNOS expression [52]. In addition, lactones ((4S)-hydroxy-(8)-methoxyl-(5S)-(H)-guaia1(10),7(11)-dien-12,8-olide and curcuminol G isolated from Curcuma kwangsiensis proved significant anti-inflammatory activity. They inhibited carrageenan-induced paw edema in vitro; at a concentration of 20 μg/mL they proved better inhibitory ratios on IL-1β and COX-2 than dexamethasone [53]. Michael and colleagues proved the inhibitory potential of rudbeckolide 5-LOX (lipoxygenase) by 84.9% at 10 μg/mL which might indicate that it would have the potential in preventing inflammation [54].

    4. Antimalarial Activity

    Malaria is a disease that threatens human wellbeing and affects millions of people worldwide. This disease is caused by different species of the genus Plasmodium [55]. Artemisinin is the second treatment after quinine, and artemisinin derivatives are known as antimalarial compounds. This compound has been used as a drug since 1979, mostly in patients with chloroquine-sensitive or chloroquine-resistant strains of P. falciparum [56]. Its key pharmacophore is 1,2,4-trioxolane cycle spiro-conjugated with sesquiterpene δ-lactone [57]. The Pereira group tested limonoids and their derivatives from biomass after the production of andiroba oil for their in vitro and in vivo antiplasmodial activity. 6α-Acetoxygedunin and 6α-hydroxydeacetylgedunin (Figure 16) possessed the best in vitro activity against the P. falciparum K1 strain, with IC50 values of 7.0 and 5.0 μM, respectively. Compound a in Figure 16 was also tested in vivo in a rodent malaria model against P. berghei NK65. Compared to untreated animals, 65.7% suppression of parasitemia was observed at the oral dose of 100 mg/kg/day [58].

    Figure 16. Antiplasmodial limonoids (a,b).

    The Moon team analyzed the antimalarial activity of ineupatorolide A isolated from Carpesium rosulatum. In his first study, he proved its activity in vitro against a chloroquine-sensitive strain of P. falciparum (D10), resulting in an IC50 value of 0.007 μg/mL [59]. Then, the same compound was tested in vivo against P. berghei in mice. In the first 4 days of infection, the dosages of 2, 5, and 10 mg/kg/day showed blood schizontocidal activity (63.2–86.5% suppression). The authors suspect that there are two mechanisms behind the antimalarial activity–elevation of erythrocytic oxidation or/and inhibiting protein synthesis [60]. (+)-4′-Decanoyl-cis-khellactone and (+)-3′-decanoyl-cis-khellactone were isolated from Agelica purpuraefolia. Both compounds showed notable antiplasmodial activity against the D10 strain with IC50 values of 1.5 and 2.4 μM, respectively [61]. Tagitinin C was tested for its antiplasmodial activity in vivo against P. falciparum with an IC50 value of 0.33 μg/mL [62]. Another in vitro study was performed by Kraft and colleagues, and five lactones proved to be active against the chloroquine-sensitive strain of P. falciparum PoW and the chloroquine-resistant clone Dd2. 1-Desoxy-1a-peroxy-rupicolin A-8-O-acetate, rupicolin A-8-O-acetate and 1a,4a-dihydroxybishopsolicepolide showed moderate activity (IC50 values = 8.7, 12.5, 8.6 μg/mL against PoW; 17.5, 10.8, 11.7 μg/mL against Dd2, respectively). Vernodalol and its derivative 11b,13-dihydrovernodalin were more active (IC50 = 4.0 and 2.3 μg/mL against PoW; 4.8 and 1.1 μg/mL against Dd2, respectively) [63]. Pseudoguaianolide sesquiterpenoid lactones (helenalin and its derivatives) proved to be active against the asexual erythrocytic stages of P. falciparum, in vitro, with IC50 values of 0.23–7.41 µM; the best result was obtained with helenalin [64]. Oret et al. presented studies on sesquiterpenoid lactones, among which arborescin, ridentin, and hanphyllin (Figure 17) were significantly active against P. falciparum FcB1 with IC50 values ranging from 2.3 to 5.4 μg/mL [65].

    Figure 17. Antiplasmodial compounds from Artemisia gorgonum (ac).

    Pedersen and colleagues presented another in vitro active lactone against P. falciparum strain D10 and the chloroquine-resistant strain W2. The IC50 values ranged from 1.55 to 3.82 μM against the D10 strain and 2.10 to 4.94 μM against the W2 strain [66]. Next, a sesquiterpenoid lactone (urospermal A-15-O-acetate) was isolated and analyzed for its antiplasmodial activity against P. falciparum strains 3D7 and W2. In vitro studies were performed, resulting in IC50 values of 2.87 and 2.41 μM, respectively [67]. The Sawadjoon group presented a spirodihydrobenzofuran terpenic lactone that had excellent in vitro activity against P. falciparum (K1, multidrug-resistant strain), obtaining an IC50 value of 0.15 μg/mL [68]. Tetranortriterpenoids, domesticulides B–D, and five triterpenoids were tested against this same strain as in a previous study and exhibited antimalarial activity with IC50 values of 2.4–9.7 μg/mL [69]. Triterpenoid lactones (Figure 18) isolated by Greve et al. from oleo-gum-resin of Boswellia serrata presented IC50 values of 1.0 µg/mL and 1.9 µg/mL against the chloroquine-sensitive P. falciparum NF54 strain [70].

    Figure 18. Triterpenoid lactones from the oleo-gum-resin of Boswellia serrata (a,b).

    Twelve new cassane-type diterpenes were isolated by the Guoxu group. Two lactones proved to possess antimalarial activity against the K1 strain with IC50 values of 0.78 and 0.52 μM [71]. Graziose et al. presented the antiplasmodial activity results of compounds isolated from plants. Peroxyferolide and lipiferolide were tested against the D10 strain (IC50 values of 6.2 and 1.8 µg/mL, respectively) and Dd2 strain (IC50 values of 12.7 and 7.5 µg/mL, respectively). The authors suspect that the antimalarial activity of the peroxide is due to the hydroxy peroxide group, which is chemically related to the endoperoxide residue of artemisinin to which it owes its activity [72]. 2-methoxyisogermafurenolide and 8-epi-2-methoxyisogermafurenolide were isolated as a mixture from Myrrh. A combination of those two sesquiterpenoid lactones showed antiplasmodial activity against P. falciparum with an IC50 value of 2.9 mg/L [73].

    The entry is from 10.3390/ijms22095036

    References

    1. Picman, A.K.; Schneider, E.F.; Gershenzon, J. Antifungal activities of sunflower terpenoids. Biochem. Syst. Ecol. 1990, 18, 325–328.
    2. Picman, A.K.; Schneider, E.F. Inhibition of fungal growth by selected sesquiterpene lactones. Biochem. Syst. Ecol. 1993, 21, 307–314.
    3. Copp, B.R. Antimycobacterial natural products. Nat. Prod. Rep. 2003, 20, 535–557.
    4. Villarreal, M.L.; Alvarez, L.; Alonso, D.; Navarro, V.; Garcia, P.; Delgado, G. Cytotoxic and antimicrobial screening of selected terpenoids from Asteraceae species. J. Ethnopharmacol. 1994, 42, 25–29.
    5. Kamel, H.N.; Slattery, M. Terpenoids of Sinularia: Chemistry and Biomedical Applications. Pharm. Biol. 2005, 43, 253–269.
    6. Aceret, T.L.; Coll, J.C.; Uchio, Y.; Sammarco, P.W. Antimicrobial activity of the diterpenes flexibilide and sinulariolide derived from Sinularia flexibilis Quoy and Gaimard 1833 (Coelenterata: Alcyonacea, Octocorallia). Comp. Biochem. Physiol. Part C Pharmacol. Toxicol. Endocrinol. 1998, 120, 121–126.
    7. Neves, M.; Morais, R.; Gafner, S.; Stoeckli-Evans, H.; Hostettmann, K. New sesquiterpene lactones from the Portuguese liverwort Targionia lorbeeriana. Phytochemistry 1999, 50, 967–972.
    8. Kozioł, A.; Jasnowski, M.; Grela, E.; Szczepanik, M.; Gabryś, B.; Dancewicz, K.; Lochyński, S. Synthesis and Biological Activity of New 4-tert-Butylcyclohexanone Derivatives. Chem. Biodivers. 2019, 16, e1800411.
    9. Kozioł, A.; Frątczak, J.; Grela, E.; Szczepanik, M.; Gabryś, B.; Dancewicz, K.; Lochyński, S. Synthesis and biological activity of new derivatives with the preserved carane system. Nat. Prod. Res. 2020, 34, 1399–1403.
    10. Mazur, M.; Skrobiszewski, A.; Gładkowski, W.; Podkowik, M.; Bania, J.; Nawrot, J.; Klejdysz, T.; Wawrzeńczyk, C. Lactones 46. Synthesis, antifeedant and antibacterial activity of γ-lactones with a p-methoxyphenyl substituent. Pest Manag. Sci. 2016, 72, 489–496.
    11. Skrobiszewski, A.; Gładkowski, W.; Walczak, P.; Gliszczyńska, A.; Maciejewska, G.; Klejdysz, T.; Nawrot, J.A.N.; Wawrzeńczyk, C. Synthesis of β-aryl-γ-lactones and relationship: Structure—Antifeedant and antifungal activity. J. Chem. Sci. 2015, 127, 687–699.
    12. Joycharat, N.; Plodpai, P.; Panthong, K.; Yingyongnarongkul, B.; Voravuthikunchai, S.P. Terpenoid constituents and antifungal activity of Aglaia forbesii seed against phytopathogens. Can. J. Chem. 2010, 88, 937–944.
    13. Fernández, L.R.; Butassi, E.; Svetaz, L.; Zacchino, S.A.; Palermo, J.A.; Sánchez, M. Antifungal Terpenoids from Hyalis argentea var. latisquama. J. Nat. Prod. 2014, 77, 1579–1585.
    14. Wedge, D.E.; Galindo, J.C.G.; Macıas, F.A. Fungicidal activity of natural and synthetic sesquiterpene lactone analogs. Phytochemistry 2000, 53, 747–757.
    15. de Andrade, E.F.; Carpiné, D.; Dagostin, J.L.A.; Barison, A.; Rüdiger, A.L.; de Muñiz, G.I.B.; Masson, M.L. Identification and antimicrobial activity of the sesquiterpene lactone mixture extracted from Smallanthus sonchifolius dried leaves. Eur. Food Res. Technol. 2017, 243, 2155–2161.
    16. Duraipandiyan, V.; Abdullah Al-Harbi, N.; Ignacimuthu, S.; Muthukumar, C. Antimicrobial activity of sesquiterpene lactones isolated from traditional medicinal plant, Costus speciosus (Koen ex.Retz.) Sm. BMC Complement. Altern. Med. 2012, 12, 13.
    17. Radulović, N.S.; Blagojević, P.D.; Stojanović-Radić, Z.Z.; Stojanović, N.M. Antimicrobial plant metabolites: Structural diversity and mechanism of action. Curr. Med. Chem. 2013, 20, 932–952.
    18. Ren, Y.; Kinghorn, A.D. Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones. J. Med. Chem. 2020, 63, 15410–15448.
    19. Zheng, G.-Q. Cytotoxic Terpenoids and Flavonoids from Artemisia annua. Planta Med. 1994, 60, 54–57.
    20. Choi, S.Z.; Yang, M.C.; Choi, S.U.; Lee, K.R. Cytotoxic terpenes and lignans from the roots of Ainsliaea acerifolia. Arch. Pharm. Res. 2006, 29, 203–208.
    21. Duh, C.-Y.; Wang, S.-K.; Weng, Y.-L.; Chiang, M.Y.; Dai, C.-F. Cytotoxic Terpenoids from the Formosan Soft Coral Nephthea brassica. J. Nat. Prod. 1999, 62, 1518–1521.
    22. Woerdenbag, H.J.; Merfort, I.; Paßreiter, C.M.; Schmidt, T.J.; Willuhn, G.; van Uden, W.; Pras, N.; Kampinga, H.H.; Konings, A.W.T. Cytotoxicity of Flavonoids and Sesquiterpene Lactones from Arnica Species Against the GLC4 and the COLO 320 Cell Lines. Planta Med. 1994, 60, 434–437.
    23. Stojakowska, A.; Galanty, A.; Malarz, J.; Michalik, M. Major terpenoids from Telekia speciosa flowers and their cytotoxic activity in vitro. Nat. Prod. Res. 2019, 33, 1804–1808.
    24. Kuo, Y.-H.; Kuo, Y.-J.; Yu, A.-S.; Wu, M.-D.; Ong, C.-W.; Yang Kuo, L.-M.; Huang, J.-T.; Chen, C.-F.; Li, S.-Y. Two Novel Sesquiterpene Lactones, Cytotoxic Vernolide-A and -B, from Vernonia cinerea. Chem. Pharm. Bull. 2003, 51, 425–426.
    25. Maldonado, E.M.; Svensson, D.; Oredsson, S.M.; Sterner, O. A novel cytotoxic terpenoid from the flowers of Kaunia lasiophthalma Griseb. Phytochem. Lett. 2014, 8, 105–108.
    26. Aïssaoui, H.; Mencherini, T.; Esposito, T.; de Tommasi, N.; Gazzerro, P.; Benayache, S.; Benayache, F.; Mekkiou, R. Heliotropium bacciferum Forssk. (Boraginaceae) extracts: Chemical constituents, antioxidant activity and cytotoxic effect in human cancer cell lines. Nat. Prod. Res. 2019, 33, 1813–1818.
    27. Suijian, Q.; Qi, C.; Wenlie, P.; Anlong, X. Cytotoxic properties of cembranolide diterpenoids from soft coral Sinularia tenella Li. J. Trop. Oceanogr. 2002, 21, 87–91.
    28. Hsieh, P.-W.; Chang, F.-R.; McPhail, A.T.; Lee, K.-H.; Wu, Y.-C. New cembranolide analogues from the formosan soft coral Sinularia flexibilis and their cytotoxicity. Nat. Prod. Res. 2003, 17, 409–418.
    29. Pawlak, A.; Gładkowski, W.; Kutkowska, J.; Mazur, M.; Obmińska-Mrukowicz, B.; Rapak, A. Enantiomeric trans-β-aryl-δ-iodo-γ-lactones derived from 2,5-dimethylbenzaldehyde induce apoptosis in canine lymphoma cell lines by downregulation of anti-apoptotic Bcl-2 family members Bcl-xL and Bcl-2. Bioorg. Med. Chem. Lett. 2018, 28, 1171–1177.
    30. Gładkowski, W.; Skrobiszewski, A.; Mazur, M.; Gliszczyńska, A.; Czarnecka, M.; Pawlak, A.; Obmińska-Mrukowicz, B.; Maciejewska, G.; Białońska, A. Chiral δ-iodo-γ-lactones derived from cuminaldehyde, 2,5-dimethylbenzaldehyde and piperonal: Chemoenzymatic synthesis and antiproliferative activity. Tetrahedron Asymmetry 2016, 27, 227–237.
    31. Gładkowski, W.; Skrobiszewski, A.; Mazur, M.; Siepka, M.; Pawlak, A.; Obmińska-Mrukowicz, B.; Białońska, A.; Poradowski, D.; Drynda, A.; Urbaniak, M. Synthesis and anticancer activity of novel halolactones with β-aryl substituents from simple aromatic aldehydes. Tetrahedron 2013, 69, 10414–10423.
    32. Lage, H.; Duarte, N.; Coburger, C.; Hilgeroth, A.; Ferreira, M.J.U. Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells. Phytomedicine 2010, 17, 441–448.
    33. Zhang, L.; Guo, J.; Jiang, X.; Chen, X.; Wang, Y.; Li, A.; Lin, L.; Li, H.; Lu, J. Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity. Acta Pharmacol. Sin. 2020, 41, 698–705.
    34. Chen, Y.-C.; Huang, M.-Y.; Zhang, L.-L.; Feng, Z.-L.; Jiang, X.-M.; Yuan, L.-W.; Huang, R.-Y.; Liu, B.; Yu, H.; Wang, Y.-T.; et al. Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells. Chin. J. Nat. Med. 2020, 18, 517–525.
    35. Pooladanda, V.; Bandi, S.; Mondi, S.R.; Gottumukkala, K.M.; Godugu, C. Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer. Toxicol. In Vitro 2018, 51, 114–128.
    36. Arumugam, A.; Subramani, R.; Lakshmanaswamy, R. Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide. Mol. Ther. Oncolytics 2021, 20, 596–606.
    37. Chien, S.-Y.; Hsu, C.-H.; Lin, C.-C.; Chuang, Y.-C.; Lo, Y.-S.; Hsi, Y.-T.; Hsieh, M.-J.; Chen, M.-K. Nimbolide induces apoptosis in human nasopharyngeal cancer cells. Environ. Toxicol. 2017, 32, 2085–2092.
    38. Dai, G.-F.; Zhao, J.; Jiang, Z.-W.; Zhu, L.-P.; Xu, H.-W.; Ma, W.-Y.; Chen, X.-R.; Dong, R.-J.; Li, W.-Y.; Liu, H.-M. Anti-inflammatory effect of novel andrographolide derivatives through inhibition of NO and PGE2 production. Int. Immunopharmacol. 2011, 11, 2144–2149.
    39. Li, J.; Huang, W.; Zhang, H.; Wang, X.; Zhou, H. Synthesis of andrographolide derivatives and their TNF-α and IL-6 expression inhibitory activities. Bioorg. Med. Chem. Lett. 2007, 17, 6891–6894.
    40. Chib, R.; Shah, B.A.; Anand, N.; Pandey, A.; Kapoor, K.; Bani, S.; Gupta, V.K.; Sethi, V.K.; Taneja, S.C. Psilostachyin, acetylated pseudoguaianolides and their analogues: Preparation and evaluation of their anti-inflammatory potential. Bioorg. Med. Chem. Lett. 2011, 21, 4847–4851.
    41. Klaas, C.A.; Wagner, G.; Laufer, S.; Sosa, S.; Loggia, R.D.; Bomme, U.; Pahl, H.L.; Merfort, I. Studies on the Anti-Inflammatory Activity of Phytopharmaceuticals Prepared from Arnica Flowers. Planta Med. 2002, 68, 385–391.
    42. Schorr, K.; Merfort, I.; da Costa, F.B. A Novel Dimeric Melampolide and Further Terpenoids from Smallanthus sonchifolius (Asteraceae) and the Inhibition of the Transcription Factor NF-κB. Nat. Prod. Commun. 2007, 2.
    43. Chi, J.; Li, B.; Dai, W.; Liu, L.; Zhang, M. Highly oxidized sesquiterpenes from Artemisia austro-yunnanensis. Fitoterapia 2016, 115, 182–188.
    44. Xia, G.; Zhou, L.; Ma, J.; Wang, Y.; Ding, L.; Zhao, F.; Chen, L.; Qiu, F. Sesquiterpenes from the essential oil of Curcuma wenyujin and their inhibitory effects on nitric oxide production. Fitoterapia 2015, 103, 143–148.
    45. González, Y.; Doens, D.; Santamaría, R.; Ramos, M.; Restrepo, C.M.; Barros de Arruda, L.; Lleonart, R.; Gutiérrez, M.; Fernández, P.L. A Pseudopterane Diterpene Isolated From the Octocoral Pseudopterogorgia acerosa Inhibits the Inflammatory Response Mediated by TLR-Ligands and TNF-Alpha in Macrophages. PLoS ONE 2013, 8, e84107.
    46. Premprasert, C.; Tewtrakul, S.; Plubrukarn, A.; Wungsintaweekul, J. Anti-inflammatory activity of diterpenes from Croton stellatopilosus on LPS-induced RAW264.7 cells. J. Nat. Med. 2013, 67, 174–181.
    47. Cheng, H.-H.; Cheng, Y.-B.; Hwang, T.-L.; Kuo, Y.-H.; Chen, C.-H.; Shen, Y.-C. Randainins A–D, Based on Unique Diterpenoid Architectures, from Callicarpa randaiensis. J. Nat. Prod. 2015, 78, 1823–1828.
    48. Garayev, E.; Herbette, G.; Di Giorgio, C.; Chiffolleau, P.; Roux, D.; Sallanon, H.; Ollivier, E.; Elias, R.; Baghdikian, B. New sesquiterpene acid and inositol derivatives from Inula montana L. Fitoterapia 2017, 120, 79–84.
    49. Pan, L.-L.; Xu, P.; Luo, X.-L.; Wang, L.-J.; Liu, S.-Y.; Zhu, Y.-Z.; Hu, J.-F.; Liu, X.-H. Shizukaol B, an active sesquiterpene from Chloranthus henryi, attenuates LPS-induced inflammatory responses in BV2 microglial cells. Biomed. Pharmacother. 2017, 88, 878–884.
    50. Shen, C.-P.; Luo, J.-G.; Yang, M.-H.; Kong, L.-Y. Sesquiterpene dimers from the roots of Chloranthus holostegius with moderate anti-inflammatory activity. Phytochemistry 2017, 137, 117–122.
    51. Fang, X.; Xu, X.-K.; Wang, G.-W.; Zeng, R.-T.; Tian, X.-H.; Shi, Z.-R.; Zhuo, Z.-G.; Shen, Y.-H.; Zhang, W.-D. Guaianolide sesquiterpenoids from Ainsliaea yunnanensis. Phytochemistry 2017, 139, 47–55.
    52. Feng, Z.-L.; Zhang, T.; Liu, J.-X.; Chen, X.-P.; Gan, L.-S.; Ye, Y.; Lin, L.-G. New podolactones from the seeds of Podocarpus nagi and their anti-inflammatory effect. J. Nat. Med. 2018, 72, 882–889.
    53. Yuan, H.-L.; Zhao, Y.-L.; Ding, C.-F.; Zhu, P.-F.; Jin, Q.; Liu, Y.-P.; Ding, Z.-T.; Luo, X.-D. Anti-inflammatory and antinociceptive effects of Curcuma kwangsiensis and its bioactive terpenoids in vivo and in vitro. J. Ethnopharmacol. 2020, 259, 112935.
    54. Michael, B.R.; Gedara, S.R.; Amer, M.M.A.; Stevenson, L.; Ahmed, A.F. A new highly oxygenated pseudoguaianolide with 5-LOX inhibitory activity from Rudbeckia hirta L. flowers. Nat. Prod. Res. 2013, 27, 2281–2285.
    55. Grigg, M.J.; Snounou, G. Plasmodium simium: A Brazilian focus of anthropozoonotic vivax malaria? Lancet Glob. Health 2017, 5, e961–e962.
    56. Klayman, D.L. Qinghaosu (artemisinin): An antimalarial drug from China. Science 1985, 228, 1049–1055.
    57. Torrens, F.; Castellano, G. Triazole-derived, artesunate and metabolic pathways for artemisinin. In Modern Green Chemistry and Heterocyclic Compounds: Molecular Design, Synthesis, and Biological Evaluation; Innovations in Physical Chemistry; Apple Academic Press: Boca Raton, FL, USA, 2020; pp. 137–143. ISBN 9781000029178.
    58. Pereira, T.B.; Rocha e Silva, L.F.; Amorim, R.C.N.; Melo, M.R.S.; Zacardi de Souza, R.C.; Eberlin, M.N.; Lima, E.S.; Vasconcellos, M.C.; Pohlit, A.M. In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production. Malar. J. 2014, 13, 317.
    59. Moon, H.-I. Antiplasmodial activity of ineupatorolides A from Carpesium rosulatum. Parasitol. Res. 2007, 100, 1147–1149.
    60. Chung, I.-M.; Kim, M.-Y.; Moon, H.-I. Antiplasmodial activity of sesquiterpene lactone from Carpesium rosulatum in mice. Parasitol. Res. 2008, 103, 341–344.
    61. Chung, I.-M.; Ghimire, B.K.; Kang, E.-Y.; Moon, H.-I. Antiplasmodial and cytotoxic activity of khellactone derivatives from Angelica purpuraefolia chung. Phyther. Res. 2010, 24, 469–471.
    62. Goffin, E.; Ziemons, E.; de Mol, P.; do Céu de Madureira, M.; Martins, A.P.; da Cunha, A.P.; Philippe, G.; Tits, M.; Angenot, L.; Frederich, M. In Vitro Antiplasmodial Activity of Tithonia diversifolia and Identification of its Main Active Constituent: Tagitinin C. Planta Med. 2002, 68, 543–545.
    63. Kraft, C.; Jenett-Siems, K.; Siems, K.; Jakupovic, J.; Mavi, S.; Bienzle, U.; Eich, E. In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe. Phyther. Res. 2003, 17, 123–128.
    64. François, G.; Passreiter, C.M. Pseudoguaianolide sesquiterpene lactones with high activities against the human malaria parasite Plasmodium falciparum. Phyther. Res. 2004, 18, 184–186.
    65. Ortet, R.; Prado, S.; Mouray, E.; Thomas, O.P. Sesquiterpene lactones from the endemic Cape Verdean Artemisia gorgonum. Phytochemistry 2008, 69, 2961–2965.
    66. Pedersen, M.M.; Chukwujekwu, J.C.; Lategan, C.A.; van Staden, J.; Smith, P.J.; Staerk, D. Antimalarial sesquiterpene lactones from Distephanus angulifolius. Phytochemistry 2009, 70, 601–607.
    67. Jansen, O.; Tits, M.; Angenot, L.; Nicolas, J.-P.; de Mol, P.; Nikiema, J.-B.; Frédérich, M. Anti-plasmodial activity of Dicoma tomentosa (Asteraceae) and identification of urospermal A-15-O-acetate as the main active compound. Malar. J. 2012, 11, 289.
    68. Sawadjoon, S.; Kittakoop, P.; Isaka, M.; Kirtikara, K.; Madla, S.; Thebtaranonth, Y. Antiviral and Antiplasmodial Spirodihydrobenzofuran Terpenes from the Fungus Stachybotrys nephrospora. Planta Med. 2004, 70, 1085–1087.
    69. Saewan, N.; Sutherland, J.D.; Chantrapromma, K. Antimalarial tetranortriterpenoids from the seeds of Lansium domesticum Corr. Phytochemistry 2006, 67, 2288–2293.
    70. Greve, H.L.; Kaiser, M.; Brun, R.; Schmidt, T.J. Terpenoids from the Oleo-Gum-Resin of Boswellia serrata and Their Antiplasmodial Effects In Vitro. Planta Med. 2017, 83, 1214–1226.
    71. Ma, G.; Wu, H.; Chen, D.; Zhu, N.; Zhu, Y.; Sun, Z.; Li, P.; Yang, J.; Yuan, J.; Xu, X. Antimalarial and Antiproliferative Cassane Diterpenes of Caesalpinia sappan. J. Nat. Prod. 2015, 78, 2364–2371.
    72. Graziose, R.; Rathinasabapathy, T.; Lategan, C.; Poulev, A.; Smith, P.J.; Grace, M.; Lila, M.A.; Raskin, I. Antiplasmodial activity of aporphine alkaloids and sesquiterpene lactones from Liriodendron tulipifera L. J. Ethnopharmacol. 2011, 133, 26–30.
    73. Greve, H.L.; Kaiser, M.; Schmidt, T.J. Investigation of Antiplasmodial Effects of Terpenoid Compounds Isolated from Myrrh. Planta Med. 2020, 86, 643–654.
    More